Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy

Annals of Neurology

Volumn 39, Issue 5, 1996, Pages 625-635

  Hafer Macko, C E ^a   Sheikh, K A ^a   Li, C Y ^b   Ho, T W ^a   Cornblath, D R ^a   McKhann, G M ^a,c   Asbury, A K ^d   Griffin, J W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Second Teaching Hospital   (China)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ULTRASTRUCTURE; COMPLEMENT ACTIVATION; DEMYELINATING NEUROPATHY; ELECTRON MICROSCOPY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPATHOGENESIS; MACROPHAGE FUNCTION; PRIORITY JOURNAL; SCHWANN CELL;

ACUTE DISEASE; AUTOPSY; BIOLOGICAL MARKERS; CELL MEMBRANE; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR MEMBRANES; MACROPHAGES; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; MYELIN SHEATH; NERVE FIBERS; POLYRADICULONEUROPATHY; SCHWANN CELLS; SPINAL NERVE ROOTS;

EID: 0029946073     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410390512     Document Type: Article

References (59)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Medicine 1969;48:173-215
2. Guillain G, Barré JA, Strohl A. Sur un syndrome de radiculonebrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux. Bull Soc Med Hop Paris 1916;40:1462
3. Arnason BGW, Soliven B. Acute inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, Griffin JW, et al, eds. Peripheral neuropathy. 3rd ed. Philadelphia: WB Saunders, 1993:1437-1497
4. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126
5. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J Neurol Sci 1993;116:185-192
6. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 1995;118:577-595
7. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996;39: 17-28
8. Haymaker W, Kernohan JW. The Landry-Guillain-Barré syndrome. A clinicopathologic report of fifty fatal cases and a critique of the literature. Medicine 1949;28:59-141
9. Prineas JW. Pathology of the Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):6-19
10. Prineas JW. Acute idiopathic polyneuritis. An electron microscope study. Lab Invest 1972;26:133-147
11. Wisniewski H, Terry RD, Whitaker JN, et al. Landry-Guillain-Barré syndrome: a primary demyelinating disease. Arch Neurol 1969;21:269-276
12. Carpenter S. An ultrastructural study of an acute fatal case of the Guillain-Barré syndrome. J Neurol Sci 1972;15:125-140
13. Osterman PO, Lundemo G, Pirskanen R, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculo-neuropathy. Lancet 1984;2:1296-1298
14. French Cooperative Group. Cooperative randomized trial of plasma exchange (P.E.) in Guillain-Barré syndrome (GBS). Preliminary results. Ann Med Interne (Paris) 1984;135:8
15. Guillain-Barré Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-1104
16. Hartung H-P, Schwenke C, Bitter-Suermann D, Toyka KV. Guillain-Barré syndrome: Activated complement components C3a and C5a in CSF. Neurology 1987;37:1006-1009
17. Koski CL, Sanders ME, Swoveland PT, et al. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. J Clin Invest 1987;80:1492-1497
18. Sanders ME, Koski CL, Robbins D, et al. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J Immunol 1986;136:4456-4459
19. Nyland H, Matre R, Mork S. Immunological characterization of sural nerve biopsies from patients with Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):80-86
20. Luijten JAFM, Baart de la Faille-Kuyper EH. The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves: an immunohistochemical study of the Guillain-Barré syndrome. Preliminary communication. J Neurol Sci 1972;15:219-224
21. Hays AP, Lee SSL, Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 1988;18:231-244
22. Nyland H, Aarli JA. Guillain-Barré syndrome: demonstration of antibodies to peripheral nerve tissue. Acta Neurol Scand 1978;58:35-43
23. Melnick SC. Thirty-eight cases of the Guillain-Barré syndrome: an immunological study. BMJ 1963;1:368-373
24. Latov N, Gross RB, Kastelman J, et al. Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology 1981;31:1530-1534
25. Koski CL, Humphrey R, Shin ML. Anti-peripheral myelin antibodies in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc Natl Acad Sci USA 1985; 82:905-909
26. Koski CL, Gratz E, Sutherland J, Mayer RF. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome. Ann Neurol 1986;19:573-577
27. Vriesendorp FJ, Mayer RF, Koski CL. Kinetics of anti-peripheral nerve myelin antibody in patients with Guillain-Barré syndrome treated and not treated with plasmapheresis. Arch Neurol 1991;48:858-861
28. Dubois-Dalcq M, Buyse M, Buyse G, Gorce F. The action of Guillain-Barré syndrome serum on myelin: a tissue culture and electron microscopic analysis. J Neurol Sci 1971;13:67-83
29. Dowling PC, Murray MR, Whitaker JN. Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 1971;24:136-144
30. Sawant-Mane S, Clark MB, Koski CL. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes. Ann Neurol 1991; 29:397-404
31. Feasby TE, Hahn AF, Gilbert JJ. Passive transfer studies in Guillain-Barré polyneuropathy. Neurology (NY) 1982;32: 1159-1167
32. Saida T, Saida K, Lisak RP, et al. In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol 1982;11:69-75
33. Sumner AJ, Saida K, Saida T, et al. Acute conduction block associated with experimental anti-serum mediated demyelination of peripheral nerve. Ann Neurol 1982;11:469-477
34. Metral S, Raphael JC, Hort-Legrand CJ, Elkharrat D. Demyelinating activity of serum from patients with Guillain-Barré syndrome. Beneficial effect of plasma exchange. Rev Neurol (Paris) 1989;145:312-320
35. Osterman PO, Vedeler CA, Ryberg B, et al. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange. J Neurol 1988;235: 285-289
36. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (in press)
37. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342
38. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580
39. Monaco S, Bonetti B, Ferrari S, et al. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 1990;322:649-652
40. Prineas JW. Demyelination and remyelination in recurrent idiopathic polyneuropathy. An electron microscope study. Acta Neuropathol (Berl) 1971;18:34-57
41. Law SK, Levine RP. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 1977;74:2701-2705
42. Lachmann PJ, Pangburn MK, Oldroyd RG. Breakdown of C3 after complement activation: identification of a new fragment, C3g, using monoclonal antibodies. J Exp Med 1982;156:205-216
43. Stoll G, Schmidt B, Jander S, et al. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991;30:147-155
44. Feasby TE, Gilbert JJ, Hahn AF, Neilson M. Complement depletion suppresses Lewis rat experimental allergic neuritis. Brain Res 1987;419:97-103
45. Jung S, Toyka KV, Hartung H-P. Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats. Neurosci Lett 1995;200:1-4
46. 2-reactive T cells in experimental allergic neuritis. J Neuroimmunol 1995;57:77-84
47. Saida K, Saida T, Brown MJ, Silberberg DH. In vivo demyelination induced by intraneural injection of antigalactocerebroside serum. Am J Pathol 1979;95:99-116
48. Hahn AF, Feasby TE, Wilkie L, Lovgren D. Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis. Muscle Nerve 1993;16:1174-1180
49. Koski CL, Vanguri P, Shin ML. Activation of the alternative pathway of complement by human peripheral nerve myelin. J Immunol 1985;134:1810-1814
50. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987; 37:242-256
51. Hirano A, Cook SD, Whitaker JN, et al. Fine structural aspects of demyelination in vitro. The effects of Guillain-Barré serum. J Neuropathol Exp Neurol 1971;30:249-265
52. Brechenmacher C, Vital C, Deminiere C, et al. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 1987;6:19-24
53. Saida K, Sumner AJ, Saida T, et al. Antiserum mediated demyelination: relation between remyelination and functional recovery. Ann Neurol 1980;8:12-24
54. Hall SM, Gregson NA. The in vivo and ultrastructural effects of the injection of lysophosphatidyl choline into myelinated peripheral nerve fibers of the adult mouse. J Cell Sci 1971;9; 769-789
55. Smith KJ, Hall SM. Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. J Neurol Sci 1988;83:37-53
56. Smith KJ, Hall SM, Schauf CL. Vesicular demyelination induced by raised intracellular calcium. J Neurol Sci 1985;71: 19-37
57. Schlaepfer WW. Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore. Nature 1977;265: 734-736
58. Blaurock AE, Yale JL. Calcium ions trigger the expansion in bistable myelin. Neurosci Lett 1987;73:167-172
59. Vanguri P, Shin ML. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. J Biol Chem 1988;263:7228-7234